Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma - Seite 3

Contacts

NEOVACS - Corporate Communication & Investor Relations
Charlène Masson
[phone]
[e-mail]

NEWCAP- Media
Annie-Florence Loyer
[phone] / + 33 6 88 20 35 59
[e-mail]
Léa Jacquin
[phone] / [phone]
[e-mail]

ORPHEON FINANCE - Financial Communication and Investor Relations
James Palmer
[phone]
[e-mail]

---

^[1] Pawankar: Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organization Journal 2014 7:12.

Press release

---

This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NEOVACS via Globenewswire